From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network. // The Journal of Prevention of Alzheimer's Disease. – URL: https://www.sciencedirect.com/science/article/pii/S2274580726001792?dgcid=rss_sd_all
From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network. The Journal of Prevention of Alzheimer's Disease. https://www.sciencedirect.com/science/article/pii/S2274580726001792?dgcid=rss_sd_all
“From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network.” The Journal of Prevention of Alzheimer's Disease.
@article{article90910,
title = {From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network},
journal = {The Journal of Prevention of Alzheimer's Disease},
url = {https://www.sciencedirect.com/science/article/pii/S2274580726001792?dgcid=rss_sd_all}
}